| Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress |
Globe Newswire |
03/30 |
08:00 |
| Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates |
Globe Newswire |
03/30 |
07:48 |
| MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue |
Globe Newswire |
03/30 |
07:45 |
| Fancamp Acquires Iron Ore Royalty and Provides Corporate Update |
Globe Newswire |
03/30 |
07:45 |
| WISeKey’s WISeSat.Space Subsidiary Successfully Launches Its 21st Satellite to Low Earth Orbit with SpaceX |
Globe Newswire |
03/30 |
07:36 |
| Cambodia advances a scam center law with penalties of up to life in prison |
AP Online |
03/30 |
07:33 |
| FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy |
Globe Newswire |
03/30 |
07:30 |
| Anavex Life Sciences Provides Comprehensive Regulatory Update |
Globe Newswire |
03/30 |
07:30 |
| Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update |
Globe Newswire |
03/30 |
07:30 |
| BridgeBio Submits NDA to FDA for BBP-418 for Individuals Living with LGMD2I/R9 |
Globe Newswire |
03/30 |
07:30 |
| Bombardier Announces Extension of Consent Solicitation with Respect to its 7.35% Debentures due 2026 |
Globe Newswire |
03/30 |
07:30 |
| BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder |
Globe Newswire |
03/30 |
07:30 |
| Palvella Therapeutics Announces Scientific Publication in Journal of Vascular Anomalies Highlighting the Infiltrative Growth and Therapeutic Challenges of Microcystic Lymphatic Malformations |
Globe Newswire |
03/30 |
07:30 |
| Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate |
Globe Newswire |
03/30 |
07:30 |
| Capitalzodiac Unveils "Geo-Matrix" – A Revolutionary Analytical Framework for the Global Strategic Minerals Sector |
Globe Newswire |
03/30 |
07:28 |
| Could a Democrat really replace Marjorie Taylor Greene? This retired Army general is trying |
AP Online |
03/30 |
07:27 |
| Can-Fite’s Partner Vetbiolix Completes Enrollment in Phase 2 Osteoarthritis Study in Dogs Treated with Piclidenoson; Data Expected in Q3 2026 |
Globe Newswire |
03/30 |
07:20 |
| Appili Therapeutics to Exhibit at World Vaccine Congress Washington |
Globe Newswire |
03/30 |
07:19 |
| Yasam Ayavefe Highlights Early Booking and Travel Clarity for Mileo Hotels 2026 |
Globe Newswire |
03/30 |
07:17 |
| Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update |
Globe Newswire |
03/30 |
07:05 |
| urban-gro, Inc. Positions for Entry into Multi-Billion-Dollar T20 Cricket Market with LPL Season Six Player Auction on May 15, 2026 via IPG Platform |
Globe Newswire |
03/30 |
07:05 |
| Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Production Hybrids, Achieving Key Milestone in its Aggressive Scale-Up Plan |
Globe Newswire |
03/30 |
07:05 |
| Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury’s Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus® Microstent |
Globe Newswire |
03/30 |
07:05 |
| PMGC Holdings Inc. [NASDAQ: ELAB] Reports 2025 Annual Results and Files Form 10-K, Company Expands Asset Base to $13.8M, a 43% Increase from 2024 |
Globe Newswire |
03/30 |
07:03 |
| Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study |
Globe Newswire |
03/30 |
07:01 |
